◆ TICKERBASEOpen interactive view →
◆ TICKERBASE · GLOBAL STOCK FINANCIAL DATA LIBRARY

Home › All stocks › S › SLP

Simulations Plus Inc (SLP) Financial History

20 years of revenue, earnings, cash-flow and balance-sheet history from public filings.

HEALTHCARE · HEALTH INFORMATION SERVICES · DATA UPDATED 2026-10-06

Simulations Plus Inc (SLP) operates in the HEALTH INFORMATION SERVICES industry and is headquartered in Research Triangle Park, United States with about 212 employees. Its market capitalization is roughly $374 million. In the fiscal year ended 2025-08-31, SLP reported $79M in revenue and ($65M) in net income.

Simulations Plus, Inc. develops drug discovery and development software for modeling and simulation, and prediction of molecular properties utilizing artificial intelligence and machine learning based technology worldwide. It operates through Software and Services segments.

Interactive charts & full statements → Open the SLP valuation workbench →

SLP Revenue & Earnings History — Annual Income Statement

Income statementTTM → 2026-05-312025-08-312024-08-312023-08-312022-08-312021-08-312020-08-312019-08-312018-08-312017-08-312016-09-302016-08-312015-08-312014-08-312013-08-312012-08-312011-08-312010-08-312009-08-312008-08-312007-08-31
Total Revenue$82M$79M$70M$60M$54M$46M$42M$34M$30M$24M$18M$20M$18M$11M$10M$9M$9M$11M$9M$9M$9M
Gross Profit$52M$46M$43M$48M$43M$36M$31M$25M$22M$18M$14M$15M$14M$10M$8M$8M$7M$8M$7M$7M$7M
Gross Margin %63.4%58.4%61.6%80.5%79.9%77.2%74.4%73.4%73.0%73.9%76.4%77.0%76.0%85.8%83.7%84.0%82.2%76.2%74.6%76.6%76.5%
Operating Income (EBIT)$12M($71M)$6M$9M$15M$11M$12M$11M$10M$8M$6M$7M$6M$4M$4M$4M$4M$3M$2M$2M$3M
Operating Margin %14.0%-89.3%8.8%14.6%27.7%24.2%27.9%31.4%34.7%34.2%32.0%36.2%32.0%38.7%40.4%38.2%40.4%26.8%19.8%24.3%28.3%
Net Income$8M($65M)$10M$10M$12M$10M$9M$9M$9M$6M$4M$5M$4M$3M$3M$3M$3M$2M$1M$2M$1M
Net Margin %9.9%-81.7%14.2%16.7%23.2%21.1%22.4%25.3%30.1%24.0%21.0%24.8%21.0%26.4%28.7%32.0%31.1%20.1%15.4%19.2%16.6%
EBITDA$13M$15M$18M$13M$19M$15M$14M$13M$13M$10M—$9M$8M$5M$5M$5M$4M$4M$3M$3M$3M
Earnings Per Share (EPS)$0.40$-3.22$0.49$0.49$0.60$0.47$0.50$0.48$0.50$0.33—$0.29$0.23$0.18$0.18$0.19$0.17$0.13$0.08$0.10$0.08
Shares Outstanding (M)20M20M20M20M21M21M19M18M18M18M—17M17M16M16M16M16M17M17M18M18M

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

SLP Quarterly Revenue & Earnings — Last 8 Quarters

Quarterly income statement2026-05-312026-02-282025-11-302025-08-312025-05-312025-02-282024-11-302024-08-31
Total Revenue$22M$24M$18M$17M$20M$22M$19M$19M
Gross Profit$15M$16M$11M$10M$13M$13M$10M$7M
Gross Margin %69.1%66.5%59.1%56.4%64.0%58.5%54.0%36.6%
Operating Income (EBIT)$4M$6M$1M$1M($74M)$3M$0M($1M)
Operating Margin %20.6%23.2%3.9%3.8%-364.5%12.1%0.7%-6.2%
Net Income$4M$5M$1M($1M)($67M)$3M$0M$1M
Net Margin %16.3%18.7%3.7%-3.9%-330.6%13.7%1.1%4.5%
EBITDA$1M$7M$2M$2M$5M$6M$3M$3M
Earnings Per Share (EPS)$0.18$0.22$0.03$-0.03$-3.35$0.15$0.01$0.04
Shares Outstanding (M)20M20M20M20M20M20M20M20M

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

SLP Free Cash Flow History

Cash flowTTM → 2026-05-312025-08-312024-08-312023-08-312022-08-312021-08-312020-08-312019-08-312018-08-312017-08-312016-09-302016-08-312015-08-312014-08-312013-08-312012-08-312011-08-312010-08-312009-08-312008-08-312007-08-31
Cash from Operations (CFO)$26M$18M$13M$22M$18M$19M$11M$12M$9M$7M$7M$5M$7M$5M$3M$4M$3M$3M$2M$2M$3M
Capital Expenditures (CapEx)$3M$1M$1M$4M$4M$5M$3M$2M$2M$2M$0M$1M$1M$4M$1M$1M$1M$1M$1M$1M$1M
Free Cash Flow (FCF)$24M$17M$13M$18M$14M$15M$8M$10M$7M$5M$7M$4M$6M$1M$1M$3M$2M$2M$2M$2M$2M
FCF Margin %29.2%22.0%18.2%29.5%25.8%31.5%20.0%28.5%23.5%22.0%38.6%20.9%32.2%12.3%13.7%28.0%27.8%18.4%19.4%18.6%26.3%
Dividends Paid—$0M$5M$5M$5M$5M$4M$4M$4M$3M$3M$3M$3M$3M$4M$2M—————

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

SLP Quarterly Free Cash Flow — Last 8 Quarters

Quarterly cash flow2026-05-312026-02-282025-11-302025-08-312025-05-312025-02-282024-11-302024-08-31
Cash from Operations (CFO)$10M$6M$4M$6M$8M$6M($1M)$2M
Capital Expenditures (CapEx)$1M$0M$1M$1M$0M$0M$0M$1M
Free Cash Flow (FCF)$9M$6M$3M$5M$8M$6M($1M)$1M
FCF Margin %43.1%26.2%18.1%27.5%38.5%25.0%-7.2%5.0%
Dividends Paid———$0M$0M$0M$0M$1M

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

SLP Balance Sheet History

Balance sheet2026-05-312025-08-312024-08-312023-08-312022-08-312021-08-312020-08-312019-08-312018-08-312017-08-312016-08-312015-08-312014-08-312013-08-312012-08-312011-08-312010-08-312009-08-312008-08-312007-08-312006-08-31
Total Assets$153M$132M$208M$193M$191M$182M$170M$46M$44M$39M$28M$27M$21M$16M$17M$16M$15M$12M$12M$9M$7M
Cash & Cash Equivalents$35M$31M$10M$58M$52M$37M$49M$11M$9M$6M$8M$9M$9M$10M$13M$10M$10M$7M$6M$5M$2M
Total Liabilities$14M$7M$25M$23M$12M$16M$14M$8M$12M$13M$5M$8M$6M$2M$2M$2M$2M$2M$2M$2M$2M
Total Debt (Short + Long-Term)$0M$0M$0M$0M$0M$0M$0M$0M$6M$6M$2M$4M$3M$0M$0M$0M$0M$0M$0M$0M$0M
Total Shareholders' Equity$139M$125M$182M$170M$178M$166M$156M$38M$32M$26M$23M$20M$15M$14M$15M$14M$13M$11M$10M$8M$6M

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive SLP viewer.

Other Companies in HEALTH INFORMATION SERVICES

← SLONAll “S” companiesSLQD →

About TickerBase · Data methodology & sources · Privacy · Terms

TickerBase is provided for educational and informational purposes only. It does not constitute financial, investment, tax, or legal advice, or a recommendation to buy, sell, or hold any security. No price targets are published; any per-share value shown in the valuation workbench is generated entirely from reader-supplied assumptions and is not the publisher's view of fair value. Past performance does not predict future results. Figures are approximate and drawn from public filings; one-time items are noted where identified. Do your own research and consult a licensed professional before making any investment decision. The author may or may not hold positions in the securities discussed.